FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Proposal to Exempt Dietary Supplements in Some Drug Studies

[ Price : $8.95]

Federal Register proposed rule: FDA proposes to amend its regulations on INDs to exempt certain clinical investigations of lawfull...

Proposal to Replace IND Annual Reporting Requirement

[ Price : $8.95]

Federal Register proposed rule: FDA proposes to replace its current annual reporting requirement for INDs with a new requirement: ...

Remel Recalls Thermo Scientific Sensititre Plates

[ Price : $8.95]

Remel recalls Thermo Scientific Gram Negative IVD AST Sensititre Plates due to the risk of potential false susceptible results for...

Janssen Files BLA for Myeloma Therapy

[ Price : $8.95]

Janssen Pharmaceutical files a BLA for talquetamab for treating patients with relapsed or refractory multiple myeloma.

2 Roche Alzheimers Tests Cleared by FDA

[ Price : $8.95]

FDA grants Roche 510(k) clearance for its Elecsys beta-Amyloid (1-42) CSF II (Abeta42) and Elecsys Phospho-Tau (181P) CSF (pTau181...

Input Sought on Advanced Manufacturing Paper

[ Price : $8.95]

FDA seeks feedback on a discussion paper entitled Distributed Manufacturing and Point-of-Care Manufacturing of Drugs.

35 No-Longer-Marketed NDAs Withdrawn

[ Price : $8.95]

Federal Register notice: FDA withdraws approval of 35 NDAs at the request of their sponsors.

ICH Continuous Manufacturing Guide Adopted

[ Price : $8.95]

FDA adopts an international guidance entitled Continuous Manufacturing of Drug Substances and Drug Products Q13.

Guide on Transfusion-Transmitted Malaria

[ Price : $8.95]

Federal Register notice: FDA makes available a final guidance entitled Recommendations to Reduce the Risk of Transfusion-Transmitt...

Norlex Not Withdrawn Over Safety/Efficacy

[ Price : $8.95]

Federal Register notice: FDA determines that Norflex (orphenadrine citrate) injection and extended-release tablets were not withdr...